GH replacement in adults: Interactions with other pituitary hormone deficiencies and replacement therapies

European Journal of Endocrinology

Volumn 161, Issue SUPPL. 1, 2009, Pages

  Filipsson, Helena ^a   Johannsson, Gudmundur ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISONE ACETATE; ESTRADIOL; ESTROGEN; GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; PLACEBO; SOMATOMEDIN C; THYROTROPIN; THYROXINE;

AGE DISTRIBUTION; CLINICAL FEATURE; CLINICAL TRIAL; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG MONITORING; DRUG RESPONSE; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOPITUITARISM; HYPOTHYROIDISM; MORNING DOSAGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADRENAL INSUFFICIENCY; ADULT; BIOLOGICAL MARKERS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GLUCOCORTICOIDS; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; HYPOTHYROIDISM; MALE; MIDDLE AGED; PITUITARY HORMONES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; THYROXINE;

EID: 70450163077     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0319     Document Type: Review

References (126)

1. Carroll PV, Christ ER, Bengtsson B-Å, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sönksen PH, Tanaka T & Thorner M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Journal of Clinical Endocrinology and Metabolism 1998 83 382-395. (Pubitemid 28496511)
2. Cuneo RC, Salomon F, Wiles CM & Sönksen PH. Skeletal muscle performance in adults with growth hormone deficiency. Hormone Research 1990 33 55-60. (Pubitemid 20261755)
3. Filipsson H & Johannsson G. Management of glucocorticoid replacement in adult growth hormone deficiency. Hormone Research 2007 67 155-164. (Pubitemid 46272297)
4. Filipsson H, Monson JP, Koltowska-Häggström M, Mattsson A & Johannsson G. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. Journal of Clinical Endocrinology and Metabolism 2006 91 3954-3961. (Pubitemid 44536870)
5. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC & Stewart PM. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001 357 425-431.
6. Regal M, Paramo C, Sierra SM & Garcia-Mayor RV. Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clinical Endocrinology 2001 55 735-740. (Pubitemid 34008744)
7. Lindholm J & Nielsen EH. Pituitary-gonadal axis: historical notes. Pituitary 2008 12 226-235.
8. Salomon F, Cuneo RC, Hesp R & Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine 19893211797-1803.
9. Jorgensen JO, Pedersen SA, Laurberg P, Weeke J, Skakkebaek NE & Christiansen JS. Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. Journal of Clinical Endocrinology and Metabolism 1989 69 1127-1132. (Pubitemid 20010037)
10. Rosén T & Bengtsson B-Å. Premature mortality due to cardiovascular diseases in hypopituitarism. Lancet 1990 336 285-288. (Pubitemid 20229130)
11. Bulow B, Hagmar L, Mikoczy Z, Nordstrom CH & Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clinical Endocrinology 1997 46 75-81. (Pubitemid 27072849)
12. Bates AS, Van't Hoff W, Jones PJ & Clayton RN. The effect of hypopituitarism on life expectancy. Journal of Clinical Endocrinology and Metabolism 1996 81 1169-1172.
13. Svensson J, Bengtsson BA, Rosen T, Oden A & Johannsson G. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. Journal of Clinical Endocrinology and Metabolism 2004 89 3306-3312. (Pubitemid 38960692)
14. Rosen T, Johannsson G, Johansson JO & Bengtsson BA. Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. A review paper. Hormone Research 1995 43 93-99.
15. Sesmilo G, Miller KK, Hayden D & Klibanski A. Inflammatory cardiovascular risk markers in women with hypopituitarism. Journal of Clinical Endocrinology and Metabolism 2001 86 5774-5781. (Pubitemid 33152623)
16. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T & Thorne M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. Journal of Clinical Endocrinology and Metabolism 1998 83 382-395.
17. Gotherstrom G, Bengtsson BA, Bosaeus I, Johannsson G & Svensson J. A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults. Journal of Clinical Endocrinology and Metabolism 2007 6 6. (Pubitemid 46562361)
18. Gotherstrom GE, Elbornsson M, Stibrant-Sunnerhagen K, Bengtsson B-Å, Johannsson G & Svensson J. Ten years of growth hormone (GH) replacement normalizes muscle strength in GH deficient adults. Journal of Clinical Endocrinology and Metabolism 2009 94 809-816.
19. Koltowska-Häggström M, Mattsson AF, Monson JP, Kind P, Badia X, Casanueva FF, Busschbach J, Koppeschaar HP & Johannsson G. Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life? European Journal of Endocrinology 2006 155 109-119.
20. Gibney J, Wallace JD, Spinks T, Schnorr L, Ranicar A, Cuneo RC, Lockhart S, Burnand KG, Salomon F, Sonksen PH & Russell- Jones D. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. Journal of Clinical Endocrinology and Metabolism 1999 84 2596-2602. (Pubitemid 30641978)
21. Wirén L, Bengtsson B-Å & Johannsson G. Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency. Clinical Endocrinology 1998 48 613-620. (Pubitemid 28252998)
22. Abs R, Mattsson AF, Bengtsson BA, Feldt-Rasmussen U, Goth MI, Koltowska-Haggstrom M, Monson JP, Verhelst J & Wilton P. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Growth Hormone & IGF Research 2005 15 349-359. (Pubitemid 41408413)
23. Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. European Journal of Endocrinology 2007 157 695-700.
24. Pekic S, Doknic M, Djurovic M, Damjanovic S, Petakov M, Miljic D, Dieguez C, Casanueva FF & Popovic V. The influence of serum cortisol levels on growth hormone responsiveness to GH-releasing hormone plus GH-releasing peptide-6 in patients with hypocortisolism. Hormones 2003 2 243-249.
25. Andersen M, Stoving RK, Hangaard J, Petersen PH & Hagen C. The effect of short-term cortisol changes on growth hormone responses to the pyridostigmine-growth-hormone-releasinghormone test in healthy adults and patients with suspected growth hormone deficiency. Clinical Endocrinology 1998 49 241-249. (Pubitemid 28372655)
26. Tzanela M, Karavitaki N, Stylianidou C, Tsagarakis S & Thalassinos NC. Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome. Clinical Endocrinology 2004 60 309-314. (Pubitemid 38297120)
27. Schmid C, Zwimpfer C, Brandle M, Krayenbuhl PA, Zapf J & Wiesli P. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism. Clinical Endocrinology 2006 65 706-711.
28. Brauman H, Smets P & Corvilain J. Comparative study of growth hormone response to hypoglycemia in normal subjects and in patients with primary myxedema or hyperthyroidism before and after treatment. Journal of Clinical Endocrinology and Metabolism 1973 36 1162-1174.
29. Williams T, Maxon H, Thorner MO & Frohman LA. Blunted growth hormone (GH) response to GH-releasing hormone in hypothyroidism resolves in the euthyroid state. Journal of Clinical Endocrinology and Metabolism 1985 61 454-456. (Pubitemid 15243954)
30. Ramos-Dias JC, Yateman M, Camacho-Hubner C, Grossman A & Lengyel AM. Low circulating IGF-I levels in hyperthyroidism are associated with decreased GH response to GH-releasing hormone. Clinical Endocrinology 1995 43 583-589.
31. Miell JP, Taylor AM, Zini M, Maheshwari HG, Ross RJ & Valcavi R. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. Journal of Clinical Endocrinology and Metabolism 1993 76 950-955. (Pubitemid 23110844)
32. Burgess JA, Smith BR & Merimee TJ. Growth hormone in thyrotoxicosis: effect of insulin-induced hypoglycemia. Journal of Clinical Endocrinology and Metabolism 1966 26 1257-1260.
33. Ramos-Dias JC, Pimentel-Filho F, Reis AF & Lengyel AM. Different growth hormone (GH) response to GH-releasing peptide and GH-releasing hormone in hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 1996 81 1343-1346. (Pubitemid 126423252)
34. De Leo V, Lanzetta D, D'Antona D & Danero S. Growth hormone secretion in premenopausal women before and after ovariectomy: effect of hormone replacement therapy. Fertility and Sterility 1993 60 268-271. (Pubitemid 23228156)
35. Bondanelli M, Ambrosio MR, Margutti A, Franceschetti P, Zatelli MC & degli Uberti EC. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone. Neuroendocrinology 2003 77 380-387.
36. Mukherjee A, Ryder WD, Jostel A & Shalet SM. Prolactin deficiency is independently associated with reduced insulin-like growth factor I status in severely growth hormone-deficient adults. Journal of Clinical Endocrinology and Metabolism 2006 91 2520-2525. (Pubitemid 44024612)
37. Beentjes JA, Tjeerdsma G, Sluiter WJ & Dullaart RP. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia. Clinical Endocrinology 1996 45 391-398. (Pubitemid 26383415)
38. Wake DJ, Rask E, Livingstone DE, Soderberg S, Olsson T & Walker BR. Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. Journal of Clinical Endocrinology and Metabolism 2003 88 3983-3988. (Pubitemid 37034555)
39. Paulsen SK, Pedersen SB, Jorgensen JO, Fisker S, Christiansen JS, Flyvbjerg A & Richelsen B. Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue. Journal of Clinical Endocrinology and Metabolism 2006 91 1093-1098. (Pubitemid 43357786)
40. Gelding SV, Taylor NF, Wood PJ, Noonan K, Weaver JU, Wood DF & Monson JP. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity. Clinical Endocrinology 1998 48 153-163. (Pubitemid 28091045)
41. Weaver JU, Thaventhiran L, Noonan K, Burrin JM, Taylor NF, Norman MR & Monson JP. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clinical Endocrinology 1994 41 639-648. (Pubitemid 24336867)
42. Swords FM, Carroll PV, Kisalu J, Wood PJ, Taylor NF & Monson JP. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement. Clinical Endocrinology 2003 59 613-620. (Pubitemid 37357623)
43. Giavoli C, Libe R, Corbetta S, Ferrante E, Lania A, Arosio M, Spada A & Beck-Peccoz P. Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary- adrenal axis in adult GH-deficient patients. Journal of Clinical Endocrinology and Metabolism 2004 89 5397-5401. (Pubitemid 39518415)
44. Diederich S, Eigendorff E, Burkhardt P, Quinkler M, Bumke- Vogt C, Rochel M, Seidelmann D, Esperling P, Oelkers W& Bahr V. 11Beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids. Journal of Clinical Endocrinology and Metabolism 2002 87 5695-5701. (Pubitemid 36034378)
45. Plotz CM, Knowlton AI & Ragan C. The natural history of Cushings syndrome. American Journal of Medicine 1952 13 597-614.
46. Lukert BP & Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Annals of Internal Medicine 1990 112 352-364.
47. Mason AS, Meade TW, Lee JA & Morris JN. Epidemiological and clinical picture of Addison's disease. Lancet 1968 2 744-747.
48. Mills JL, Schonberger LB, Wysowski DK, Brown P, Durako SJ, Cox C, Kong F & Fradkin JE. Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. Journal of Pediatric 2004 144 430-436. (Pubitemid 38457343)
49. Bergthorsdottir R, Leonsson-Zachrisson M, Oden A & Johannsson G. Premature mortality in patients with Addison's disease: a population-based study. Journal of Clinical Endocrinology and Metabolism 2006 91 4849-4853. (Pubitemid 44917317)
50. Bensing S, Brandt L, Tabaroj F, Sjoberg O, Nilsson B, Ekbom A, Blomqvist P & Kampe O. Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clinical Endocrinology 2008 69 697-704.
51. Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Winterer JC & Loriaux DL. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. Journal of Clinical Endocrinology and Metabolism 1991 72 39-45. (Pubitemid 21921653)
52. Kraan GP, Dullaart RP, Pratt JJ, Wolthers BG, Drayer NM & De Bruin R. The daily cortisol production reinvestigated in healthy men. The serum and urinary cortisol production rates are not significantly different. Journal of Clinical Endocrinology and Metabolism 1998 83 1247-1252. (Pubitemid 28496402)
53. Besser GM & Jeffcoate WJ. Endocrine and metabolic diseases. Adrenal diseases. BMJ 1976 1 448-451.
54. Howlett TA. An assessment of optimal hydrocortisone replacement therapy. Clinical Endocrinology 1997 46 263-268. (Pubitemid 27174327)
55. Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R & Weetman AP. Glucocorticoid replacement therapy: are patients over treated and does it matter? Clinical Endocrinology 1997 46 255-261.
56. Barbetta L, Dall'Asta C, Re T, Libe R, Costa E & Ambrosi B. Comparison of different regimens of glucocorticoid replacement therapy in patients with hypoadrenalism. Journal of Endocrinological Investigation 2005 28 632-637. (Pubitemid 43162872)
57. Crown A & Lightman S. Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clinical Endocrinology 2005 63 483-492. (Pubitemid 41626741)
58. Zelissen PM, Croughs RJ, van Rijk PP & Raymakers JA. Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Annals of Internal Medicine 1994 120 207-210.
59. Wichers M, Springer W, Bidlingmaier F & Klingmuller D. The influence of hydrocortisone substitution on the quality of life and parameters of bone metabolism in patients with secondary hypocortisolism. Clinical Endocrinology 1999 50 759-765. (Pubitemid 29284510)
60. al-Shoumer KA, Beshyah SA, Niththyananthan R & Johnston DG. Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults. Clinical Endocrinology 1995 42 85-90.
61. Dunne FP, Elliot P, Gammage MD, Stallard T, Ryan T, Sheppard MC & Stewart PM. Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism. Clinical Endocrinology 1995 43 623-629.
62. McConnell EM, Bell PM, Ennis C, Hadden DR, McCance DR, Sheridan B & Atkinson AB. Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism. Clinical Endocrinology 2002 56 195-201. (Pubitemid 34233956)
63. Danilowicz K, Bruno OD, Manavela M, Gomez RM & Barkan A. Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study. Pituitary 2008 11 279-285.
64. Hahner S, Loeffler M, Fassnacht M, Weismann D, Koschker AC, Quinkler M, Decker O, Arlt W & Allolio B. Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. Journal of Clinical Endocrinology and Metabolism 2007 92 3912-3922. (Pubitemid 47607641)
65. Lovas K, Loge JH & Husebye ES. Subjective health status in Norwegian patients with Addison's disease. Clinical Endocrinology 2002 56 581-588. (Pubitemid 34595724)
66. Gurnell EM, Hunt PJ, Curran SE, Conway CL, Pullenayegum EM, Huppert FA, Compston JE, Herbert J & Chatterjee VK. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. Journal of Clinical Endocrinology and Metabolism 2008 93 400-409. (Pubitemid 351240809)
67. Lovas K & Husebye ES. Continuous subcutaneous hydrocortisone infusion in Addison's disease. European Journal of Endocrinology 2007 157 109-112. (Pubitemid 47162573)
68. Persani L, Ferretti E, Borgato S, Faglia G & Beck-Peccoz P. Circulating thyrotropin bioactivity in sporadic central hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2000 85 3631-3635. (Pubitemid 30828566)
69. Persani L. Hypothalamic thyrotropin-releasing hormone and thyrotropin biological activity. Thyroid 1998 8 941-946. (Pubitemid 28514188)
70. Patel YC & Burger HG. Serum thyrotropin (TSH) in pituitary and-or hypothalamic hypothyroidism: normal or elevated basal levels and paradoxical responses to thyrotropin-releasing hormone. Journal of Clinical Endocrinology and Metabolism 1973 37 190-196.
71. Andersen S, Pedersen KM, Bruun NH & Laurberg P. Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. Journal of Clinical Endocrinology and Metabolism 2002 87 1068-1072. (Pubitemid 36121067)
72. Yamakita N, Komaki T, Takao T, Murai T, Hashimoto K & Yasuda K. Usefulness of thyrotropin (TSH)-releasing hormone test and nocturnal surge of TSH for diagnosis of isolated deficit of TSH secretion. Journal of Clinical Endocrinology and Metabolism 2001 86 1054-1060. (Pubitemid 32322981)
73. Rose SR, Lustig RH, Pitukcheewanont P, Broome DC, Burghen GA, Li H, Hudson MM, Kun LE & Heideman RL. Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. Journal of Clinical Endocrinology and Metabolism 1999 84 4472-4479. (Pubitemid 30677662)
74. Agha A, Walker D, Perry L, Drake WM, Chew SL, Jenkins PJ, Grossman AB & Monson JP. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clinical Endocrinology 2007 66 72-77. (Pubitemid 44952497)
75. Alexopoulou O, Beguin C, De Nayer P & Maiter D. Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients. European Journal of Endocrinology 2004 150 1-8. (Pubitemid 38159735)
76. Lania A, Persani L & Beck-Peccoz P. Central hypothyroidism. Pituitary 2008 11 181-186.
77. Ferretti E, Persani L, Jaffrain-Rea ML, Giambona S, Tamburrano G & Beck-Peccoz P. Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. Journal of Clinical Endocrinology and Metabolism 1999 84 924-929. (Pubitemid 29138219)
78. Porretti S, Giavoli C, Ronchi C, Lombardi G, Zaccaria M, Valle D, Arosio M & Beck-Peccoz P. Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T(4) therapy become mandatory? Journal of Clinical Endocrinology and Metabolism 2002 87 2042-2045.
79. Losa M, Scavini M, Gatti E, Rossini A, Madaschi S, Formenti I, Caumo A, Stidley CA & Lanzi R. Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency. Thyroid 2008 18 1249-1254.
80. Hubina E, Mersebach H, Rasmussen AK, Juul A, Sneppen SB, Goth MI & Feldt-Rasmussen U. Effect of growth hormone replacement therapy on pituitary hormone secretion and hormone replacement therapies in GHD adults. Hormone Research 2004 61 211-217. (Pubitemid 38490203)
81. Giavoli C, Porretti S, Ferrante E, Cappiello V, Ronchi CL, Travaglini P, Epaminonda P, Arosio M & Beck-Peccoz P. Recombinant hGH replacement therapy and the hypothalamus- pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism? Clinical Endocrinology 2003 59 806-810.
82. Grubeck-Loebenstein B, Vierhapper H, Waldhausl W & Nowotny P. Thyroid function in adrenocortical insufficiency during withdrawal and re-administration of glucocorticoid substitution. Acta Endocrinologica 1983 103 254-258.
83. Abdullatif HD & Ashraf AP. Reversible subclinical hypothyroidism in the presence of adrenal insufficiency. Endocrine Practice 2006 12 572.
84. Caron PJ, Nieman LK, Rose SR & Nisula BC. Deficient nocturnal surge of thyrotropin in central hypothyroidism. Journal of Clinical Endocrinology and Metabolism 1986 62 960-964.
85. Rose SR, Manasco PK, Pearce S & Nisula BC. Hypothyroidism and deficiency of the nocturnal thyrotropin surge in children with hypothalamic-pituitary disorders. Journal of Clinical Endocrinology and Metabolism 1990 70 1750-1755. (Pubitemid 20192933)
86. Patel YC, Alford FP & Burger HG. The 24-hour plasma thyrotrophin profile. Clinical Science 1972 43 71-77.
87. Vanhaelst L, Van Cauter E, Degaute JP & Golstein J. Circadian variations of serum thyrotropin levels in man. Journal of Clinical Endocrinology and Metabolism 1972 35 479-482.
88. Weeke J. Circadian variation of the serum thyrotropin level in normal subjects. Scandinavian Journal of Clinical and Laboratory Investigation 1973 31 337-342.
89. Romijn JA & Wiersinga WM. Decreased nocturnal surge of thyrotropin in nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism 1990 70 35-42. (Pubitemid 20045922)
90. Monig H, Stracke L, Arendt T & Kloehn S. Blunted nocturnal TSH surge does not indicate central hypothyroidism in patients after pituitary surgery. Experimental and Clinical Endocrinology and Diabetes 1999 107 89-92. (Pubitemid 29082075)
91. Bartalena L, Martino E, Brandi LS, Falcone M, Pacchiarotti A, Ricci C, Bogazzi F, Grasso L, Mammoli C & Pinchera A. Lack of nocturnal serum thyrotropin surge after surgery. Journal of Clinical Endocrinology and Metabolism 1990 70 293-296. (Pubitemid 20045960)
92. Romijn JA, Adriaanse R, Brabant G, Prank K, Endert E & Wiersinga WM. Pulsatile secretion of thyrotropin during fasting: a decrease of thyrotropin pulse amplitude. Journal of Clinical Endocrinology and Metabolism 1990 70 1631-1636. (Pubitemid 20192915)
93. Weeke J & Laurberg P. Diural TSH variations in hypothyroidism. Journal of Clinical Endocrinology and Metabolism 1976 43 32-37.
94. Faglia G, Beck-Peccoz P, Ferrari C, Ambrosi B, Spada A, Travaglini P & Paracchi S. Plasma thyrotropin response to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders. Journal of Clinical Endocrinology and Metabolism 1973 37 595-601.
95. Faglia G. The clinical impact of the thyrotropin-releasing hormone test. Thyroid 1998 8 903-908. (Pubitemid 28514182)
96. Hartoft-Nielsen ML, Lange M, Rasmussen AK, Scherer S, Zimmermann-Belsing T & Feldt-Rasmussen U. Thyrotropinreleasing hormone stimulation test in patients with pituitary pathology. Hormone Research 2004 61 53-57. (Pubitemid 38316473)
97. Auernhammer CJ & Vlotides G. Anterior pituitary hormone replacement therapy - a clinical review. Pituitary 2007 10 1-15. (Pubitemid 46562803)
98. Querido A & Stanbury JB. Primary and secondary hypothyroidism. Journal of Clinical Endocrinology and Metabolism 1950 10 1192-1201.
99. Stanley MM & Astwoor EB. The response of the thyroid gland in normal human subjects to the administration of thyrotropin as shown by studies with I131. Endocrinology 1949 44 49-60.
100. Robbins J. Pharmacology of bovine and human thyrotropin: an historical perspective. Thyroid 1999 9 451-453. (Pubitemid 29244922)
101. Palmieri EA, Fazio S, Lombardi G & Biondi B. Subclinical hypothyroidism and cardiovascular risk: a reason to treat? Treatments in Endocrinology 2004 3 233-244.
102. Fatourechi V. Upper limit of normal serum thyroid-stimulating hormone: a moving and now an aging target? Journal of Clinical Endocrinology and Metabolism 2007 92 4560-4562.
103. Lehmke J, Bogner U, Felsenberg D, Peters H & Schleusener H. Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women. Clinical Endocrinology 1992 36 511-517.
104. Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA & Breteler MM. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam Study. Clinical Endocrinology 2000 53 733-737.
105. Smit JW, Eustatia-Rutten CF, Corssmit EP, Pereira AM, Frolich M, Bleeker GB, Holman ER, van der Wall EE, Romijn JA & Bax JJ. Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 2005 90 6041-6047. (Pubitemid 41606523)
106. Auer J, Scheibner P, Mische T, Langsteger W, Eber O & Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. American Heart Journal 2001 142 838-842. (Pubitemid 33016203)
107. Parle JV, Maisonneuve P, Sheppard MC, Boyle P & Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001 358 861-865. (Pubitemid 32900566)
108. Rose SR. Isolated central hypothyroidism in short stature. Pediatric Research 1995 38 967-973.
109. Carrozza V, Csako G, Yanovski JA, Skarulis MC, Nieman L, Wesley R & Pucino F. Levothyroxine replacement therapy in central hypothyroidism: a practice report. Pharmacotherapy 1999 19 349-355. (Pubitemid 29118177)
110. Shimon I, Cohen O, Lubetsky A & Olchovsky D. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism. Thyroid 2002 12 823-827.
111. Slawik M, Klawitter B, Meiser E, Schories M, Zwermann O, Borm K, Peper M, Lubrich B, Hug MJ, Nauck M, Olschewski M, Beuschlein F & Reincke M. Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine. Journal of Clinical Endocrinology and Metabolism 2007 92 4115-4122. (Pubitemid 350074720)
112. Leung KC, Johannsson G, Leong GM & Ho KK. Estrogen regulation of growth hormone action. Endocrine Reviews 2004 25 693-721. (Pubitemid 39366048)
113. Wolthers T, Hoffman DM, Nugent AG, Duncan MW, Umpleby M & Ho KK. Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. American Journal of Physiology. Endocrinology and Metabolism 2001 281 E1191-E1196. (Pubitemid 34001193)
114. Svensson J, Johannsson G & Bengtsson B-Å. Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test. Clinical Endocrinology 1997 46 579-586. (Pubitemid 27286931)
115. Gibney J, Johannsson G, Leung KC & Ho KK. Comparison of the metabolic effects of raloxifene and oral estrogen in postmenopausal and growth hormone-deficient women. Journal of Clinical Endocrinology and Metabolism 2005 90 3897-3903. (Pubitemid 41058148)
116. Cook DM, Ludlam WH & Cook MB. Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 1999 84 3956-3960.
117. Johannsson G, Bjarnason R, Bramnert M, Carlsson LMS, Degerblad M, Manhem P, Rosén T, Thorén M & Bengtsson B-Å. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH binding protein, body mass index, age and gender. Journal of Clinical Endocrinology and Metabolism 1996 81 1575-1581. (Pubitemid 126423256)
118. Burman P, Johansson AG, Siegbahn A, Vessby B & Karlsson FA. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. Journal of Clinical Endocrinology and Metabolism 1997 82 550-555. (Pubitemid 27068627)
119. Gotherstrom G, Svensson J, Koranyi J, Alpsten M, Bosaeus I, Bengtsson B & Johannsson G. A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. Journal of Clinical Endocrinology and Metabolism 2001 86 4657-4665. (Pubitemid 33026070)
120. Johannsson G, Grimby G, Stibrant Sunnerhagen K & Bengtsson B-Å. Two years of growth hormone (GH) treatment increases isometric and isokinetic muscle strength in GH-defi- cient adults. Journal of Clinical Endocrinology and Metabolism 1997 82 2877-2884. (Pubitemid 27385642)
121. Beshyah SA & Johnston DG. Cardiovascular disease and risk factors in adults with hypopituitarism. Clinical Endocrinology 1999 50 1-15. (Pubitemid 29079362)
122. Johansson J-O, Fowelin J, Landin K, Lager I & Bengtsson B-Å. Growth hormone-deficient adults are insulin-resistant. Metabolism 1995 44 1126-1129. (Pubitemid 26084031)
123. Mah PM, Webster J, Jonsson P, Feldt-Rasmussen U, Koltowska- Häggström M & Ross RJ. Estrogen replacement in women of fertile years with hypopituitarism. Journal of Clinical Endocrinology and Metabolism 2005 90 5964-5969. (Pubitemid 41606512)
124. Mauras N, Hayes V, Welch S, Rini A, Helgeson K, Dokler M, Veldhuis JD & Urban RJ. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. Journal of Clinical Endocrinology and Metabolism 1998 83 1886-1892. (Pubitemid 28496311)
125. Phillip M, Palese T, Hernandez ER, Roberts CT Jr, LeRoit D & Kowarski AA. Effect of testosterone on insulin-like growth factor-I (IGF-I) and IGF-I receptor gene expression in the hypophysectomized rat. Endocrinology 1992 130 2865-2870.
126. Johannsson G, Gibney J, Wolthers T, Leung KC & Ho KK. Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men. Journal of Clinical Endocrinology and Metabolism 2005 90 3989-3994. (Pubitemid 41065024)